Lexicon Pharmaceuticals, Inc.

( )
LXRX After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
MRNAModerna, Inc. 14.65%71.780.0%$1188.28m
NVAXNovavax, Inc. 10.56%104.32102.0%$894.13m
AMGNAmgen, Inc. 0.40%250.041.3%$686.39m
REGNRegeneron Pharmaceuticals, Inc. -0.80%615.882.5%$630.55m
GILDGilead Sciences, Inc. 0.47%76.681.0%$625.83m
BIIBBiogen, Inc. -0.85%276.521.6%$592.84m
VXRTVaxart, Inc. 51.88%12.120.0%$534.03m
VRTXVertex Pharmaceuticals, Inc. -3.27%284.821.9%$460.66m
ILMNIllumina, Inc. -0.30%369.133.5%$296.54m
BMRNBioMarin Pharmaceutical, Inc. -1.32%124.404.3%$210.55m
BNTXBioNTech SE 10.55%77.780.0%$206.32m
ALXNAlexion Pharmaceuticals, Inc. -1.65%107.031.9%$204.83m
SGENSeattle Genetics, Inc. -3.31%168.586.1%$186.16m
SRNESorrento Therapeutics, Inc. -4.22%7.721.8%$182.30m
IMMUImmunomedics, Inc. -3.27%39.9711.0%$172.59m

Company Profile

Lexicon Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. Its drug candidates include XERMELO, Zynquista, and LX9211. The company was founded by Brian P. Zambrowicz and Arthur T. Sands on July 7, 1995 and is headquartered in The Woodlands, TX.